Reddit stock price today barely moves as CTO share-sale filing and AI-search thesis collide
30 December 2025
2 mins read

Reddit stock price today barely moves as CTO share-sale filing and AI-search thesis collide

NEW YORK, December 30, 2025, 12:33 ET — Regular session

  • Reddit shares were little changed at midday as U.S. stocks traded quietly into year-end.
  • A regulatory filing showed Reddit’s CTO sold stock under a pre-arranged trading plan.
  • A Needham analyst said Reddit’s visibility in AI-generated answers is becoming more valuable as referral traffic tightens.

Reddit shares were little changed on Tuesday, holding near $234.60 in midday trading, as investors digested an insider sale disclosed in a regulatory filing and a fresh round of bullish talk on the company’s role in AI-driven search.

The muted move matters because Reddit has been one of the market’s standout winners since its March 2024 debut, and attention is shifting from momentum to whether the platform can keep turning AI-driven attention into ad dollars. A year-end tape that has been broadly calm leaves company-specific signals — even routine ones like insider filings — with more room to grab headlines. 1

A Form 4 filed late Monday showed Chief Technology Officer Christopher Brian Slowe sold 14,000 shares on Dec. 22 at prices ranging from $231.49 to $240.10, while also exercising and converting shares in related transactions. The filing said the sales were made under a Rule 10b5-1 trading plan adopted on May 9, 2025. 2

A 10b5-1 plan is a pre-set instruction insiders use to sell stock on a schedule, designed to reduce the risk that trades are influenced by material non-public information. Traders still track the disclosures for clues on supply and sentiment, particularly after big runs. 2

On the demand side, Needham analyst Laura Martin flagged the same dynamic that has helped push Reddit into the AI “winner” bucket: “As overall referral traffic shrinks, the platforms that AI answers cite (like Reddit) become increasingly valuable,” she wrote in a client note. 1

Reddit’s bull case has increasingly leaned on that visibility, alongside advertising — which accounts for most of its revenue — and data-licensing deals with AI companies including OpenAI and Alphabet, Investors.com reported. 1

Reddit has pointed investors to its scale and engagement as the foundation for monetization. The company’s investor relations site listed 116 million daily active uniques and 443 million-plus weekly active uniques as of Sept. 30, 2025. 3

The next hard check is execution against management’s own targets. In its most recent results update, Reddit estimated fourth-quarter revenue of $655 million to $665 million and adjusted EBITDA of $275 million to $285 million; adjusted EBITDA is a profit metric that strips out interest, taxes and some non-cash items to highlight operating performance. 4

Peers with ad-heavy models were modestly higher on the day, with Snap up about 1.3%, Pinterest up about 1.0% and Meta Platforms up about 1.1%, leaving Reddit lagging even as the broader social-media group held firm.

Reddit traded between $229.33 and $236.99 on Tuesday, with volume around 1.4 million shares by late morning in New York, according to market data.

Investors are watching for any incremental read on AI-related traffic and ad demand as 2026 positioning begins, and for signs that data licensing can become a steadier contributor alongside ads. For now, the stock’s next move may hinge less on the Dec. 22 insider sale itself than on whether upcoming results keep the growth narrative intact. 4

Stock Market Today

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

7 February 2026
Meta closed down 1.3% Friday at $661.46, capping a 6.4% weekly drop as investors questioned heavy AI spending. Amazon and Alphabet also fell after outlining major capital outlays. Meta’s Instagram suffered a brief outage this week. Legal risks persist, with trials involving Meta set for next week in Los Angeles and New Mexico.
IAMGOLD (IAG) stock rises as gold rebounds from margin-driven selloff; Fed minutes ahead
Previous Story

IAMGOLD (IAG) stock rises as gold rebounds from margin-driven selloff; Fed minutes ahead

Johnson & Johnson stock today: JNJ slips after $3.05B Halda cancer deal closes, Barclays lifts target
Next Story

Johnson & Johnson stock today: JNJ slips after $3.05B Halda cancer deal closes, Barclays lifts target

Go toTop